Optellum showcases AI for precision lung cancer treatment at ASCO 2024 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Kersti Oselin, MD, PhD, discusses a subgroup analysis from the phase 3 PEARLS/KEYNOTE-091 study of pembrolizumab in patients with early-stage non‒small-cell lung cancer following resection.
Kaardistatakse kopsuvähihaigete raviteekond mu.ee - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mu.ee Daily Mail and Mail on Sunday newspapers.